Recent Quotes
My Watchlist
Indicators
Star 60
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Fulgent Genetics, Inc.

Fulgent Genetics Awarded Contract by the U.S. Department of Veterans Affairs to Provide Hereditary Cancer, Pharmacogenetic and Other Genetic Testing to Veterans1
From Fulgent Genetics, Inc.
Via Business Wire
Tickers FLGT
Fulgent to Announce Third Quarter 2024 Financial Results on Friday, November 8, 2024
From Fulgent Genetics, Inc.
Via Business Wire
Tickers FLGT
Fulgent Reports Second Quarter 2024 Financial Results
From Fulgent Genetics, Inc.
Via Business Wire
Tickers FLGT
Fulgent to Announce Second Quarter 2024 Financial Results on Friday, August 2, 2024
From Fulgent Genetics, Inc.
Via Business Wire
Tickers FLGT
Fulgent Reports First Quarter 2024 Financial Results
From Fulgent Genetics, Inc.
Via Business Wire
Tickers FLGT
Fulgent Genetics to Announce First Quarter 2024 Financial Results on Friday, May 3, 2024
From Fulgent Genetics, Inc.
Via Business Wire
Tickers FLGT
Fulgent Reports Fourth Quarter and Full Year 2023 Financial Results
From Fulgent Genetics, Inc.
Via Business Wire
Tickers FLGT
Fulgent Genetics to Announce Fourth Quarter and Full Year 2023 Financial Results on Wednesday, February 28, 2024
From Fulgent Genetics, Inc.
Via Business Wire
Tickers FLGT
Fulgent to Participate in the Piper Sandler 35th Annual Healthcare Conference
From Fulgent Genetics, Inc.
Via Business Wire
Tickers FLGT
Fulgent Shares Data from Two Poster Presentations at SITC 2023 Annual Meeting
From Fulgent Genetics, Inc.
Via Business Wire
Tickers FLGT
Fulgent Reports Third Quarter 2023 Financial Results
From Fulgent Genetics, Inc.
Via Business Wire
Tickers FLGT
Fulgent Announces Two Poster Presentations at SITC 2023 Annual Meeting
From Fulgent Genetics, Inc.
Via Business Wire
Tickers FLGT
Fulgent Genetics to Announce Third Quarter 2023 Financial Results on Friday November 3, 2023
From Fulgent Genetics, Inc.
Via Business Wire
Tickers FLGT
Fulgent Reports Second Quarter 2023 Financial Results
From Fulgent Genetics, Inc.
Via Business Wire
Tickers FLGT
Fulgent Genetics to Announce Second Quarter 2023 Financial Results on Friday, August 4, 2023
From Fulgent Genetics, Inc.
Via Business Wire
Tickers FLGT
Fulgent Data at ASCO 2023 Highlights Progress for Its Lead Therapeutic Oncology Candidate, FID-007, in Various Cancers
From Fulgent Genetics, Inc.
Via Business Wire
Tickers FLGT
Fulgent Announces Upcoming Presentation of Clinical Data for Its Lead Therapeutic Oncology Candidate, FID-007, at ASCO 2023 Annual Meeting
From Fulgent Genetics, Inc.
Via Business Wire
Tickers FLGT
Fulgent Reports First Quarter 2023 Financial Results
From Fulgent Genetics, Inc.
Via Business Wire
Tickers FLGT
Fulgent Genetics to Announce First Quarter 2023 Financial Results on Friday May 5, 2023
From Fulgent Genetics, Inc.
Via Business Wire
Tickers FLGT
Fulgent Reports Fourth Quarter and Full Year 2022 Financial Results
From Fulgent Genetics, Inc.
Via Business Wire
Tickers FLGT
Fulgent Genetics Launches New Beacon787 Expanded Carrier Screening Panel
From Fulgent Genetics, Inc.
Via Business Wire
Tickers FLGT
Fulgent Genetics to Announce Fourth Quarter and Full Year 2022 Financial Results on Tuesday, February 28, 2023
From Fulgent Genetics, Inc.
Via Business Wire
Tickers FLGT
Fulgent Expands Board of Directors with Addition of Reggie Groves
From Fulgent Genetics, Inc.
Via Business Wire
Tickers FLGT
Fulgent Genetics to Participate in Piper Sandler’s 34th Annual Healthcare Conference
From Fulgent Genetics, Inc.
Via Business Wire
Tickers FLGT
Fulgent Genetics Acquires Fulgent Pharma, Creating a New Paradigm in Precision Medicine for The Company
From Fulgent Genetics, Inc.
Via Business Wire
Tickers FLGT
Fulgent Genetics Reports Third Quarter 2022 Financial Results
From Fulgent Genetics, Inc.
Via Business Wire
Tickers FLGT
Fulgent Genetics to Participate in Credit Suisse’s 31st Annual Healthcare Conference
From Fulgent Genetics, Inc.
Via Business Wire
Tickers FLGT
Fulgent Genetics to Announce Third Quarter 2022 Financial Results on Monday November 7, 2022
From Fulgent Genetics, Inc.
Via Business Wire
Tickers FLGT
Fulgent Genetics Reports Second Quarter 2022 Financial Results
From Fulgent Genetics, Inc.
Via Business Wire
Tickers FLGT
Fulgent Genetics Welcomes Dr. Michael Nohaile and Dr. Leonard Post to Board of Directors
From Fulgent Genetics, Inc.
Via Business Wire
Tickers FLGT
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.